CISBIO Adopts BellBrook Labs' Transcreener Platform for Enhanced Target Screening Services

Published: Nov 15, 2007

MADISON, Wis.--(BUSINESS WIRE)--BellBrook Labs, a leading provider of high throughput screening tools for the drug discovery industry, today announced that Cisbio, a global developer of HTRF® (Homogeneous Time-Resolved Fluorescence) technology and services used in assay development and drug screening, is adopting BellBrook's Transcreener™ HTS Assay Platform as part of a technology licensing agreement.

Back to news